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Background: Consumption of plant-derived nutraceuticals and crude drugs in traditional medicine is widely
believed to confer beneficial effects in thwarting the progression of cardiovascular diseases. Rhus tripartita
(family Anacardiaceae) has been traditionally used to treat a wide range of ailments.
Methods: In the present study we investigated the protective effects of an alcoholic extract of the stem part of
Rhus tripartita male genotype (RTSM) on experimentally induced myocardial injury in rats. To this end, cardiac injury
was induced by administration of isoproterenol (ISO) and serum enzyme markers, lipid profiles and cardiac tissue
redox status were determined following RTSM treatment (250 and 500 mg/kg).
Results: As a result, RTSM treatment significantly mitigated ISO-triggered upregulation of cardiac-specific markers of
injury creatine kinase and lactate dehydrogenase. RTSM treatment significantly attenuated ISO-induced increase in
serum cholesterol and triglycerides as well alterations in serum lipoproteins. Determination of oxidative balance
showed that RTSM treatment significantly blunted ISO-induced increase in malondialdehyde and decrease in
nonprotein sulfhydryl in cardiac tissue. Six compounds were isolated and identified as gallocatechin 1, taxifolin 2,
myricetin-3-O-β-glucoside 3, catechin 4, epicatechin 5, and 3′,8-binaringenin 6. Compound 6 was isolated for the
first time from the stem part of Rhus tripartita. Furthermore, RTSM treatment enhanced the survival fraction of
cardiac cells exposed to oxidative stress in vitro.
Conclusion: We conclude that the antioxidant properties of RTSM treatment underpin its cardioprotective
pharmacological effects, thus, providing biological evidence for the treatment of cardiovascular diseases using Rhus
tripartita in indigenous medicine.
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Cardiovascular disease (CVD) is a major cause of
morbidity and mortality in the modern era and includes
conditions such as myocardial infarction, angina pectoris,
and atherosclerosis [1]. Although several mechanisms are
speculated to participate in the pathogenesis of myocardial
insufficiency, the putative roles of these processes remain
elusive. Mounting evidence suggests that deranged
myocardial redox balance, enhanced inflammation and
reduced cell survival influence normal heart function in
CVD [2]. Herbal remedies have been utilized for various
diseases including heart diseases [3, 4], as these herbs
constitute a rich source of bioactive phytochemicals such as
flavonoids, polyphenols and other constituents which have
been shown to possess beneficial effects in CVD [5, 6]. The
Anacardiaceae family of plants consists of trees, shrubs
and/or woody vines belonging mainly to the genus Rhus,
with about 250 species which occurs mostly in the tropics
and subtropics and various temperate zones of the world
[7, 8]. A number of Rhus species are used in folkloric and
traditional medicine of many countries including Saudi
Arabia. Rhus tripartita (Ucria) Grande is found wildly in
the North-Eastern part of Saudi Arabia. In Arabian
traditional medicine, different parts of Rhus tripartita plant
have been used for centuries to treat inflammatory condi-
tions as well as gastrointestinal and cardiovascular disorders
[9]. The fruits of this plant are consumed freshly and in
decoction to treat diarrhea and ulcers [10]. Previously, ex-
tracts and pure isolates of Rhus tripartita were isolated and
shown to possess robust anti-inflammatory and antioxidant
properties [11]. Rhus species were documented to possess a
wide array of pharmacological activities such as anti-
inflammatory, antinephritic, antimicrobial [12], antioxidant
and breast cancer preventive properties [13, 14]. Rhus
coriara (Sumac) was reported to be used for the prevention
and treatment of atherosclerosis [15]. Recently, an attempt
has been made to intensify the solvent extraction of total
phenols and tannins from the bark of Rhus tripartita. From
the same species of Rhus, flavonoids and isoflavonoids
have been isolated from its aerial parts and character-
ized. Furthermore, butein (a polyphenolic component)
was extracted from another species, Rhus verniciflua.
In our previous study on crateagus species, the phyto-
chemical constituents (flavonoids and proanthocyani-
dins) and the therapeutic nature such as cardiovascular
effects and antioxidant activity were conducted [16–18].
Our current research on Saudi Arabian Rhus tripartita
showed that it is rich in flavonoids and proanthocyani-
dins compounds.
On account of its wide use in Arabian traditional medi-
cine for the prevention of CVD, the present study, thus, ex-
plored the possible protective effect of an alcoholic extract
of the stem part of Rhus tripartita male genotype (RTSM)
against isoproterenol (ISO)-induced cardiac injury in rats.Methods
Plant material
Fresh sample of stem bark of Rhus tripartita was
collected in April 2013 at Hail area in the northwestern
part of Saudi Arabia. The plants were identified by an
expert Taxonomist at the Herbarium Unit. The voucher
specimens have been deposited (SY 202/2013) at the
Herbarium of the Faculty of Pharmacy, King Saud
University, Riyadh, Saudi Arabia.
Extraction and isolation
The stem of the plant was collected and air-dried at
room temperature. The dried sample was powdered;
1100 g of dried sample was extracted with 4000 ml of
80 % aqueous methanol three times. The extracts were
filtrated through Whatmann No. 1 and combined
followed by concentration using a rotary evaporator
under reduced pressure at 40 °C to yield a dry extract of
231 g (21 %). The percentage yield was expressed in
terms of air dried weight of plant materials.
The dry extract (100 g) was diffused in 400 ml of
distilled water and extracted successively with dichloro-
methane (CH2Cl2), ethyl acetate (EtOAc) and n-butanol
(n-BuOH) (3 x 300 ml) respectively. Each extract was
dried over anhydrous sodium sulfate. The organic
fractions were concentrated under reduced pressure at
temperature not exceeding 35 °C and the residual
aqueous layer was lyophilized named (RTSM1),
(RTSM2) (RTSM3) and (RTSM4) respectively. The
EtOAc fraction (RTSM2) (20 g) was subjected to a
Sephadex LH-20 column (Pharmacia) (90 x 4 cm), EtOH
was used as a mobile phase. The fractions 50 ml each
are collected and examined on TLC (Silica gel 60 F254,
layer thickness 0.2 mm, Merck), the upper layer of mix-
ture of EtOAc-HOAc-HCOOH-H2O (30/0.8/1.2/8) was
used as a mobile phase. The TLC were viewed under UV
(254 and 366 nm) before and after spraying with Neu’s
spray reagent (reagent a) and vanillin H2SO4 (reagent b).
Fractions 16-20, 21-35, 36-45, 46-60, 61-74 and 75-86
were combined together in one group and named as
(RTSM2-I), (RTSM2-II), (RTSM2-III) and (RTSM2-IV)
and (RTSM2-V) respectively.
The sub-fractions RTM2-II was subjected to Sephadex
LH-20 column chromatography using methanol as
eluent to give compounds 1 and 2. Subfraction RTM2-
III was subjected to Sephadex LH-20 using methanol as
mobile phase to give compounds 3, 4 and 5. The sub
fraction RTSM2-IV was subjected to column chroma-
tography C18-reversed-phase with MeOH-H2O (6:4) as
eluent to give compound 6.
NMR spectroscopy
NMR spectra were recorded in deuterated methanol
(CD3OD) on a Bruker DRX-400 spectrometer (Bruker
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400.13 MHz for 1H and at 100.61 MHz for 13C.In vitro cardioprotective assay
The H9C2 cells (human cardiomyoblast) were grown in
DMEM medium, supplemented with 10 % heat-
inactivated bovine serum (Gibco) and 1x penicillin-
streptomycin (Gibco) at 37 °C with 5 % CO2 supply. The
cells were seeded (0.5x105 cells/well, in triplicate) in a
96-well flat-bottom plate (Becton-Dickinson Labware)
and grown over night. Cardioprotective activity of RTSM
was determined against 2, 7-dichlorofluorescein (DCFH;
Sigma) cytotoxicity (IC50: 125 μg/ml), using MTT assay
(MTT-Cell proliferation Assay Kit, Tervigen) as de-
scribed previously [19] (Al-Yahya et al., 2016). Four
doses of RTSM (31.25, 62.5, 125, and 250 μg/ml) were
prepared in DMSO followed by dilutions in DMEM
media. (>0.1 %, final). The cells were replenished with
fresh media containing 120 μg/ml DCFH plus a dose of
RTSM, including DCFH only-treated control. The cells
were incubated for 48 h followed by MTT assay as per
the manufacturer’s instruction. The optical density (OD)
was recorded at 570 nm in a microplate reader (BioTek,
ELx800). The cell survival fraction was determined by
the non-linear regression analysis by Excel software,
using the following equation:
Survival fraction ¼ OD s½ −OD b½ 
OD c½ −OD b½ 
Where OD[s], OD[b] and OD[c] are the absorbance of
sample, blank and negative control, respectively.
Also, a direct visual investigation was made under an
inverted microscope (Optica, 40x and 100x) to observe any
morphological changes in the cells cultured with different
concentrations of RTSM and/or DCFH at 24 and 48 h.In vivo cardioprotective potential assay
Animals
The present study was approved by the Research Ethics
Committee of the College of Pharmacy, King Saud
University (Riyadh, Saudi Arabia). The handling of
animals was in compliance with the Guidelines for the
Care and Use of Laboratory Animals by the Animal Care
Center. Wistar albino male rats, 180 ± 20 g were ob-
tained from the Experimental Animal care Center of the
college of Pharmacy, King Saud University, Riyadh. The
animals were caged individually in hygienic conditions
and kept in a controlled environment with a 12 h light-
dark cycle at 22 ± 3 °C for a week before the experiment.
The animals were offered free access to purina chow diet
and water ad libitum.In vivo cardioprotective assay
Myocardial infarction (MI) induction in rats iso-
proterenol (ISO) (a synthetic catecholamine), is a well-
accepted noninvasive drug to induce MI in rat model
[20]. The physiopathological and morphological changes
of ISO-induced myocardial necrosis are similar to those
observed in humans [21]. ISO was dissolved in normal
saline and injected subcutaneously (85 mg/kg b.w.) for
two consecutive days at the interval of 24 h [20].
The animals were randomly divided into four groups,
each containing six rats. Group I (normal group; con-
trol) animals received normal saline using intragastric
tube for 14 days, and saline was administered (500 μl/
rat, s.c.) on day 13 and 14 (24 h interval). Group II (ISO
control; ISO) animals received normal saline for 14 days,
and received ISO (85 mg/kg, s.c.) on day 20 and 21
(24 h interval). Group III (RTSM + ISO) animals
received RTSM (250 mg/kg/day) orally for 21 days along
with concurrent administration of ISO (85 mg/kg, s.c. at
24 h interval) on day 20 and 21. Group IV (RTSM +
ISO) animals received RTSM (500 mg/kg/day) and ISO
(85 mg/kg, s.c. at 24 h interval) on day 20 and 21.
Estimation of marker enzymes
Levels of plasma alanine aminotransferase (ALT), aspar-
tate aminotransferase (AST) [22], lactate dehydrogenase
(LDH) [23], and creatine kinase (CK) [24] were then
estimated usingReflotron® Plus Analyzer and Roche
Diagnostic Kits (Roche Diagnostics GmbH, Mannheim,
Germany).
Estimation of lipid profile
The total cholesterol (TC) [25], triglycerides (TG) [26],
and high-density lipoproteins (HDL-C) [27] were esti-
mated in plasma using the Refloton instrument of the
specific kits (Roche Diagnostics GmbH, Mannheim,
Germany).
Lipid Peroxidation (LPO) determination
The method reported by Utley et al. [28] was followed.
The heart tissue was homogenized in0.15 M KCl (at 4 °
C, Potter-Elvehjem type C homogenizer) to give a
10 % w/v homogenate. Aliquots of homogenate (1 mL)
were incubated at 37 °C for 3 h in a metabolic shaker.
Following this,1 mL of 10 % aqueous trichloroacetic acid
(TCA) was added and mixed. The mixture was then cen-
trifuged at 800 g for 10 min. Following this, supernatant
(1 mL) was mixed with 1 mL of 0.67%thiobarbituric acid
and placed in a boiling water bath for 10 min. The mix-
ture was cooled and diluted with 1 mL distilled water.
The absorbance of the solution was then read using
spectrophotometer(UVmini-1240, Shimadzu Italia, Mi-
lano, Italy) at 532 nm. The content of malondialdehyde
Compound 6
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ence to a standard curve of MDA solution.
Estimation of Non-Protein Sulfhydryl Groups (NP-SH)
Cardiac NP-SH was measured according to the method
of Sedlak and Lindsay [29]. The heart was homogenized
in ice-cold 0.02 M ethylene diaminetetraacetic acid
(EDTA). Aliquots of 5 mL of the homogenates were
mixed in 15 mL test tubes with 4 mL of distilled water
and 1 mL of 50 % TCA. The tubes were shaken intermit-
tently for 10 min and centrifuged at 3000 rpm. Two
milliliters of supernatant were mixed with 4 mL Tris
buffer (0.4 mol/L, pH 8.9) and 0.1 mL of 5,5′-dithio-
bis(2-nitrobenzoic acid) (DTNB) and the sample was
shaken. The absorbance was read within 5 min of
addition of DTNB at 412 nm against a reagent blank.
Determination of Total Protein (TP)
The TP was estimated by the kit method, supplied by
Crescent Diagnostics, Jeddah, Saudi Arabia. The
absorbance of this complex at 546 nm is proportional
to the protein concentration. The serum total protein
was calculated using the equation: Serum total pro-
tein = Abs. sample/Abs. standard × concentration of
standard (1).
Histopathological studies
The heart tissues were fixed in 10 % buffered formalin
and processed using a VIP tissue processor. The proc-
essed tissues were then embedded in paraffin blocks and
sections of about 5 μm thickness were cut by employing
an American optical rotary microtome. These sections
were stained with hematoxylin and eosin using routine





1H NMR (CD3OD): δ 7.23 (1H, s, H-2’), 7.17 (3H, d, J
= 8.1 Hz, H-2”’, H-6’, H-6”’), 6.88 (1H, d, J = 8.4 Hz,
H-5’), 6.71 (3H, d, J = 8.1 Hz, H-3”’, H-5”’), 6.05 (1H), br
s) and 5.89 (2H, br s, H-6,H-6”, H-8), 5.34 (1H, m) and
5.23 (1H, m) (H-2, H-2”), 3.02 (2H, m, H-3ax, H-3”ax),
2.79 (1H, m) and 2.56 (1H, m) (H-3eq, H-3”eq).
13C NMR (CD3OD): δ 197.0 and 195.5 (C-4,
C-4”)166.9 and 164,7 (C-7, C-7”)164.0 (C-5), 163.5
(C-4”’), 163.2 (C-5”), 160.6 (C-4’), 157.2 (C-9), 155.2
(C-9”), 131.2 (C-6’), 129.8 (C-1’), 129.2 (C-1”’), 127.3
(C-2”’, C-6”’), 126.4 (C-2’), 120.0 (C-3’), 115.2 (C-3”’,
C-5”’), 114.8 (C-5’), 105.6 (C-!”), 102.0 (C-10, C-10”),
95.6 and 95.0 (C-6, C-6”), 94.8 (C-8), 79.2 (C-2), 78.5
(C-2”); 42.6 and 42.2 (C-3 and C-3”).In vitro cardioprotective potential of RTSM
The cardioprotective activity of RTSM against DCFH-
induced injury on cultured C9H2 cells was investigated.
While DCFH-toxicated cardiomyocytes were recovered
to ~10 % with 62.5 μg/ml dose of RTSM, supplementa-
tion with 125 and 250 μg/ml of RTSM further enhanced
the cardiomyocytes proliferation by ~15 and 30 %,
respectively. Therefore, RTSM at the best minimal dose
of 250 μg/ml showed the protective activity on cultured
cardiomyocytes.
In vivo cardioprotective potential of RTSM
To investigate the cardiovascular modulatory effects of
RTSM treatment, we used the ISO-induced myocardial
injury model in rats [31–33]. Firstly, we examined the
effect of RTSM on ISO-induced changes in serum
markers. To this end, administration of ISO (85 mg/kg)
significantly increased serum levels of the enzymes
SGOT, SGPT, GST and ALP, an effect significantly and
dose-dependently thwarted by pretreatment with 250
and 500 mg/kg RTSM (Table 1). ISO administration
further enhanced LDH and CK, cardio-specific serum
markers of injury (Table 1). As shown in Table 1,
pretreatment of rats with RTSM significantly attenuated
ISO-elicited increase in serum LDH and CK suggesting
the cardioprotective effects of RTSM treatment.
Experimental cardiac injury triggered by ISO is further
associated with an alteration of serum lipid profiles [34].
To this end, determination of serum lipids revealed that
administration of ISO significantly enhanced the serum
levels of cholesterol, triglycerides, VLDL and LDL while
significantly lowering serum HDL level (Table 2). As
shown in Table 2, treatment of rats with RTSM signifi-
cantly and dose-dependently counteracted ISO-induced
alterations in serum lipids indicating a vascular protect-
ive role of RTSM treatment.
Table 1 Effect of RTSM on serum marker enzymes of control and experimental rats
Treatments Dose
mg/kg
SGOT(U/L) SGPT(U/L) GGT(U/L) ALP(U/L) LDH(U/L) CK(U/l)
Mean ± SE % change Mean ± SE % change Mean ± SE % change Mean ± SE % change Mean ± SE % change Mean ± SE % change
Control 79.00 ± 3.31 30.01 ± 2.44 4.85 ± 0.23 217.16 ± 11.14 106.08 ± 6.45 135.16 ± 5.43
ISO only 85 200.00 ± 5.78***a 181.00 ± 7.33***a 13.65 ± 0.33***a 435.30 ± 10.02***a 165.66 ± 6.72***a 227.33 ± 10.18***a
RTSM+ ISO 250 159.00 ± 6.53***b 21↓ 150.83 ± 4.11**b 17↓ 10.55 ± 0.40***b 23↓ 379.33 ± 13.32*b 3↓ 150.00 ± 4.91b 9↓ 201.50 ± 5.51b 11↓
RTSM+ ISO 500 154.00 ± 4.01***b 23↓ 140.00 ± 5.57**b 23↓ 9.16 ± 0.25***b 33↓ 350.33 ± 11.42***b 20↓ 139.66 ± 6.19*b 9↓ 185.50 ± 7.34*b 18↓
All values represent mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001; ANOVA, followed by Dunnett’s multiple comparison test
aAs compared with normal group


















Table 2 Effect of RTSM on serum lipid metabolism and serum lipoproteins of control and experimental rats
Treatments Dose
mg/kg
Cholesterol(mg/dl) Triglycerides(mg/dl) HDL-C(mg/dl) VLDL-C(mg/dl) LDL-C(mg/dl)
Mean ± SE % change Mean ± SE % change Mean ± SE %change Mean ± SE % change Mean ± SE % change
Control 98.1 ± 5.15 54.56 ± 3.45 42.66 ± 1.17 10.91 ± 0.69 44.52 ± 5.57
ISO only 85 199.83 ± 7.21***a 155.00 ± 8.00***a 24.66 ± 1.56***a 31.001.60***a 144.16 ± 6.03***a
RTSM+ ISO 250 179.83 ± 4.33*b 10↓ 120.33 ± 3.44**b 22↓ 27.66 ± 0.76 12↑ 24.06 ± 0.68**b 23↓ 128.10 ± 4.83b 11↓
RTSM+ ISO 500 157.83 ± 5.83** 21↓ 105.61 ± 1.96***b 32↓ 32.50 ± 1.17**b 32↑ 21.12 ± 0.39***b 31↓ 104.21 ± 6.57**b 28↓
All values represent mean ± SEM. *p < 0.05
**p < 0.01, ***p < 0.001; ANOVA, followed by Dunnett’s multiple comparison test
aAs compared with control group


















Fig. 1 Effect of RTSM on the level of MDA in the heart tissue of the rats treated with Isoproteronol. All value represent mean ± SESM **P < 0.01,
***p < 0.001; ANOVA, followed by Dunnett’s multiple comparison test. aAs compared with control group. bAs compared with only ISO only groups
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role of redox sensitivity of RTSM treatment in ameliorating
ISO-induced cardiotoxicity. To this end, we determined
malondialdehyde (MDA) levels in cardiac tissue isolated
from rats administered with ISO. As a result, ISO adminis-
tration significantly upregulated tissue MDA levels, an
effect that was significantly and dose-dependently mitigated
by pretreatment with RTSM (Fig. 1).
Additional experiments were performed to further elu-
cidate the pivotal role of RTSM treatment in modulating
the redox imbalance induced by ISO. ISO treatment is
associated with decreased nonprotein sulfhydryl (NP-
SH) levels in cardiac tissue [35, 36]. As illustrated in
Fig. 2, administration of ISO significantly reduced NP-
SH levels in cardiac tissue, an effect that was signifi-
cantly and dose dependently blunted by pretreatment
with RTSM indicating that the antioxidant effects of
RTSM treatment are a critical mechanism in its cardio
protective effect. Further examination of total protein
levels in cardiac tissue revealed that ISO significantly de-
creased total protein levels, an effect that was signifi-
cantly and dose-dependently counteracted by RTSM
treatment (Fig. 3).Fig. 2 Effect of RTSM on the level of NP-SH (Nonprotein sulphydryl) in the
mean ± SEM **P < 0.01, ***p < 0.001; ANOVA, followed by Dunnett’s multipl
with only ISO only groupsDCFH is generally used to measure in vitro oxidative
stress generated by free-radicals through oxidation of
DCFH to the fluorescent DCF [37].
To confirm the antioxidant effects of RTSM treatment
in conferring a protective response against ISO-induced
cardiac injury, we analyzed the survival fraction of cardi-
omyocytes ex vivo against DCFH -toxicity. As a result,
survival fraction of cardiomyocytes treated with RTSM
(125 μg/ml) was significantly enhanced by attenuating
DCFH effect (Fig. 4).
Histological improvement of injured myocardiac tissues
by RTSM
The histology of rat cardiac tissues showed that ISO-
elicited inflammatory lesions led to structure disorders
of muscle fibers as well as infiltration of acute inflamma-
tory cells, including extravasation of red blood cells (Fig.
5a and b). The other changes observed were interstitial
edema and the appearance of vacuoles in ISO alone
treated rats. RTSM treatment mitigated ISO-induced in-
flammatory changes in cardiac tissues, indicating that
RTSM efficiently cured the tissue lesions in a dose-
dependent manner (Fig. 5c and d).heart tissue of the rats treated with Isoproteronol. All value represent
e comparison test. aAs compared with control group. bAs compared
Fig. 3 Effect of RTSM on the level of TP (Total Protein) in the heart tissue of the rats treated with Isoproteronol. All value represent mean ± SEM
*P < 0.05, ***p < 0.001; ANOVA, followed by Dunnett’s multiple comparison test. aAs compared with control group. bAs compared with only ISO
only groups
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Based on co-TLC, 1H and 13C-NMR and compared
directly with published data, compounds 1, 2, 3, 4 and 5
were isolated and identified before as gallocatechin 1,
taxifolin 2, myricetin-3-O-β-glucoside 3, catechin 4 and
epicatechin 5, respectively [6, 38, 39]. Compounds 6 was
identified as 3′,8-binaringenin. The reported structure
was confirmed by comparison with previously reported
spectral data [39, 40]. Compound 6 was isolated for the
first time from this species.
The present study reveals a, hitherto unknown, cardio-
protective pharmacological effect of RTSM in an animalFig. 4 Cardioprotective effect of RTSM against DCFH-induced cytoxicity onmodel of ISO-induced cardiotoxicity. Moreover, we show
that oxidative stress that underpins ISO-induced cardiac
injury serves as a prime target of RTSM in ameliorating
pathological changes associated with ISO administration.
Along those lines, RTSM significantly down regulated
serum enzymes indicative of cardiac injury and signifi-
cantly thwarted ISO-associated alterations in serum lipid
profiles. Furthermore, RTSM treatment robustly mitigated
ISO-induced alterations in cardiac tissue redox balance.
Mechanistically, the outcome of ISO treatment in rats
comprises a myriad of biochemical alterations in the car-
diac tissue [41]. ISO-elicited histopathological modificationscultured cardiomyoblast cells (H9C2) at 48 h post-treatment
A B
C D
Fig. 5 Photomicrography of cardiac tissue of rats showing the effect of RTSM. a Normal (control group) showing no significant pathology. H.& E.
400x; b Cardiac tissue showing myocardial necrosis with lymphohistiocytic, reaction around the necrotic myocardial fibers in rats myocardial cells
treated with ISO only. H. & E. 600x; c RTSM (250 mg/kg) plus ISO pretreatment showing slightly disorganized myocardial fibres with focal chronic
inflammation. H. & E. 600x. d RTSM (500 mg/kg) plus ISO pretreated group showing a small focus of myocardial fibres tic reaction. H. & E. 600x
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the modification of redox enzymes such as superoxide dis-
mutase, catalase and glutathione [42] as well as endogenous
redox-sensitive mediators such as nitric oxide [43] and
hydrogen sulfide. ISO-triggered generation of reactive oxy-
gen species in cardiac tissue fosters enhanced apoptosis of
cardiac cells [44] and is associated with increased cytosolic
calcium, cAMP and mitochondrial depolarization [45].
Strikingly, these changes also involve endoplasmic
reticulum stress in cardiac cells [46]. Ramifications of ISO
treatment further include modulation of various signaling
cascades including the activation of NF-kB [47] and
mitogen-activated protein kinases [48]. It is tempting to
speculate that these mechanisms participate in the amelior-
ation of oxidative stress and cardioprotectivity conferred by
RTSM treatment.
The antioxidant and cardiovascular beneficial effects
of RTSM may be attributed to its bioactive phytochem-
ical constituents. Rhus tripartita fruits were recently
shown to contain a wide array of phytochemicals but
were remarkably rich in flavones and betulinic acid [49].
Interestingly, flavones were previously reported to ameli-
orate ISO-induced cardiac injury [50] and hyperlipid-
emia [51]. Intriguingly, flavones were previously shown
to alleviate ISO-induced increase in MDA levels [52].
Accordingly, our data show that RTSM attenuated ISO-induced increased MDA levels in cardiac tissue. DCFH
is generally used to measure in vitro oxidative stress
generated by free radicals through the principle of oxida-
tion of DCFH to the fluorescent DCF [53]. In this study,
we used DCFH because of its high toxicity on cultured
cells. Our in vitro data showing cardioprotection against
DCFH-induced injury was in line with the in vivo effects
of RTSM in isoproteronol-myocardiac tissue damage in
rats. Taken together, these results confirmed the cardio-
protective potential of RTSM by using two different
toxins in two different experimental models.Conclusion
In summary, sex compounds were isolated and identi-
fied. Compound 3′,8-binaringenin (6) was isolated for
the first time from the stem part of Rhus tripartita
RTSM treatment ameliorates experimental cardiac injury
in rats effective, at least in part, by its antioxidant prop-
erties. Our study, thus, provides biological evidence for
the cardiovascular beneficial effects of Rhus tripartita
used in Arabian traditional medicine.
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